Advertisement
Screener

VANDA PHARMACEUTICALS INC. (VNDA) Preferred Stock, Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

VANDA PHARMACEUTICALS INC. Preferred Stock, Shares Authorized

VANDA PHARMACEUTICALS INC. (VNDA) had Preferred Stock, Shares Authorized of 20.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Preferred Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:PreferredStockSharesAuthorized · last filed 2026-08-06

  • 2026-06-30: Preferred Stock, Shares Authorized 20.00M shares.
  • 2026-03-31: Preferred Stock, Shares Authorized 20.00M shares.
  • 2025-12-31: Preferred Stock, Shares Authorized 20.00M shares.
  • 2025-09-30: Preferred Stock, Shares Authorized 20.00M shares.
Period endPreferred Stock, Shares Authorized
2026-06-3020.00M shares
10-Q · filed 2026-08-06
2026-03-3120.00M shares
10-Q · filed 2026-05-07
2025-12-3120.00M shares
10-Q · filed 2026-08-06
2025-09-3020.00M shares
10-Q · filed 2025-10-30
2025-06-3020.00M shares
10-Q · filed 2025-07-31
2025-03-3120.00M shares
10-Q · filed 2025-05-08
2024-12-3120.00M shares
10-K · filed 2026-02-12
2024-09-3020.00M shares
10-Q · filed 2024-11-07
2024-06-3020.00M shares
10-Q · filed 2024-08-01
2024-03-3120.00M shares
10-Q · filed 2024-05-09
2023-12-3120.00M shares
10-K · filed 2025-02-14
2023-09-3020.00M shares
10-Q · filed 2023-11-09
2023-06-3020.00M shares
10-Q · filed 2023-07-28
2023-03-3120.00M shares
10-Q · filed 2023-05-03
2022-12-3120.00M shares
10-K · filed 2024-02-08
2022-09-3020.00M shares
10-Q · filed 2022-11-03
2022-06-3020.00M shares
10-Q · filed 2022-08-04
2022-03-3120.00M shares
10-Q · filed 2022-05-06
2021-12-3120.00M shares
10-K · filed 2023-02-09
2021-09-3020.00M shares
10-Q · filed 2021-11-04
2021-06-3020.00M shares
10-Q · filed 2021-07-29
2021-03-3120.00M shares
10-Q · filed 2021-05-06
2020-12-3120.00M shares
10-K · filed 2022-02-24
2020-09-3020.00M shares
10-Q · filed 2020-10-29
2020-06-3020.00M shares
10-Q · filed 2020-08-06
2020-03-3120.00M shares
10-Q · filed 2020-05-07
2019-12-3120.00M shares
10-K · filed 2021-02-11
2019-09-3020.00M shares
10-Q · filed 2019-11-07
2019-06-3020.00M shares
10-Q · filed 2019-08-01
2019-03-3120.00M shares
10-Q · filed 2019-05-03
2018-12-3120.00M shares
10-K · filed 2020-02-26
2018-09-3020.00M shares
10-Q · filed 2018-11-07
2018-06-3020.00M shares
10-Q · filed 2018-08-02
2018-03-3120.00M shares
10-Q · filed 2018-05-02
2017-12-3120.00M shares
10-K · filed 2019-02-19
2017-09-3020.00M shares
10-Q · filed 2017-11-08
2017-06-3020.00M shares
10-Q · filed 2017-08-03
2017-03-3120.00M shares
10-Q · filed 2017-05-03
2016-12-3120.00M shares
10-K · filed 2018-02-15
2016-09-3020.00M shares
10-Q · filed 2016-11-03
2016-06-3020.00M shares
10-Q · filed 2016-07-28
2016-03-3120.00M shares
10-Q · filed 2016-05-05
2015-12-3120.00M shares
10-K · filed 2017-02-17
2015-09-3020.00M shares
10-Q · filed 2015-11-04
2015-06-3020.00M shares
10-Q · filed 2015-07-31
2015-03-3120.00M shares
10-Q · filed 2015-05-07
2014-12-3120.00M shares
10-K · filed 2016-02-12
2014-09-3020.00M shares
10-Q · filed 2014-10-27
2014-06-3020.00M shares
10-Q · filed 2014-08-08
2014-03-3120.00M shares
10-Q · filed 2014-05-08
2013-12-3120.00M shares
10-K · filed 2015-03-13
2013-09-3020.00M shares
10-Q · filed 2013-11-08
2013-06-3020.00M shares
10-Q · filed 2013-07-31
2013-03-3120.00M shares
10-Q · filed 2013-05-10
2012-12-3120.00M shares
10-K · filed 2014-02-25
2012-09-3020.00M shares
10-Q · filed 2012-11-08
2012-06-3020.00M shares
10-Q · filed 2012-08-03
2012-03-3120.00M shares
10-Q · filed 2012-05-09
2011-12-3120.00M shares
10-K · filed 2013-02-26
2011-09-3020.00M shares
10-Q · filed 2011-11-07
2011-06-3020.00M shares
10-Q · filed 2011-08-05
2010-12-3120.00M shares
10-K · filed 2012-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Evommune, Inc. (EVMN)United States$0.320B-5.10
Upstream Bio, Inc. (UPB)United States$0.284B-2.42